Pharmaceutical companies are facing challenges during post drug launch phase to take a compelling product value story to the right audience to influence greater adoption. These companies are taking the help of post-launch market studies which hold the capacity of spawning insights from a wealth of information available from different channels to help Pharma companies unveil trends and patterns about patient adherence/ switching/ adoption, physician’s sentiment, KOL’s, and salesforce competency in a cost-effective way to create competitive advantage. This paper aims to improve the way post launch market studies are conducted and analyzed with the help of HCL’s Post Market Study as a Service (PMSaaS) solution.